Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
patent litigation
Pharma
BMS, Ono sue Amgen over proposed Opdivo biosimilar
BMS and Ono are suing Amgen in Delaware over claims that its proposed biosimilar would tread on a number of patents for Opdivo.
Fraiser Kansteiner
Sep 16, 2026 11:08am
Sanofi sues Pfizer, Moderna over mRNA patents
Jul 15, 2026 3:32pm
How biosimilar developers are embracing next phase of US market
Jul 6, 2026 10:03am
Axsome bars generic rivals to narcolepsy med Sunosi until 2040
Jun 4, 2026 9:35am
In Lilly patent spat, appeals court revives $177M verdict to Teva
Apr 17, 2026 10:16am
Merck KGaA expects Mavenclad generics to deal serious blow in US
Mar 5, 2026 11:30am
